Literature DB >> 16282446

Human T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo.

Ihab Younis1, Brenda Yamamoto, Andrew Phipps, Patrick L Green.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus associated primarily with adult T-cell leukemia and neurological disease. HTLV-1 encodes the positive trans-regulatory proteins Tax and Rex, both of which are essential for viral replication. Tax activates transcription initiation from the viral long terminal repeat and modulates the transcription or activity of a number of cellular genes. Rex regulates gene expression posttranscriptionally by facilitating the cytoplasmic expression of incompletely spliced viral mRNAs. Tax and Rex mutants have been identified that have defective activities or impaired biochemical properties associated with their function. To ultimately determine the contribution of specific protein activities on viral replication and cellular transformation of primary T cells, mutants need to be characterized in the context of an infectious molecular clone. Since the tax and rex genes are in partially overlapping reading frames, mutation in one gene frequently disrupts the other, confounding interpretation of mutational analyses in the context of the virus. Here we generated and characterized a unique proviral clone (H1IT) in which the tax and rex genes were separated by expressing Tax from an internal ribosome entry site. We showed that H1IT expresses both functional Tax and Rex. In short- and long-term coculture assays, H1IT was competent to infect and immortalize primary human T cells similar to wild-type HTLV-1. In contrast, H1IT failed to efficiently replicate and persist in inoculated rabbits, thus emphasizing the importance of temporal and quantitative regulation of specific mRNA for viral survival in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282446      PMCID: PMC1287553          DOI: 10.1128/JVI.79.23.14473-14481.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation.

Authors:  M Hishizawa; K Imada; T Ishikawa; T Uchiyama
Journal:  Leukemia       Date:  2004-01       Impact factor: 11.528

2.  Transformation studies with a human T-cell leukemia virus type 1 molecular clone.

Authors:  Matthew D Anderson; Jianxin Ye; Li Xie; Patrick L Green
Journal:  J Virol Methods       Date:  2004-03-15       Impact factor: 2.014

3.  Potential immunogenicity of adult T cell leukemia cells in vivo.

Authors:  Kiyoshi Kurihara; Nanae Harashima; Shino Hanabuchi; Masato Masuda; Atae Utsunomiya; Ryuji Tanosaki; Masao Tomonaga; Takashi Ohashi; Atsuhiko Hasegawa; Takao Masuda; Jun Okamura; Yuetsu Tanaka; Mari Kannagi
Journal:  Int J Cancer       Date:  2005-03-20       Impact factor: 7.396

4.  Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein.

Authors:  Kerstin Haller; Yalin Wu; Elisabeth Derow; Iris Schmitt; Kuan-Teh Jeang; Ralph Grassmann
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Authors:  Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald L Princler; David Derse; Tom Misteli; Genoveffa Franchini
Journal:  Nat Med       Date:  2004-01-18       Impact factor: 53.440

6.  HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.

Authors:  Tomohiro Kato; Hiroshi Asahara; Manae Suzuki Kurokawa; Koushi Fujisawa; Tomoko Hasunuma; Hajime Inoue; Masanao Tsuda; Shigeru Takahashi; Satoru Motokawa; Takayuki Sumida; Kusuki Nishioka
Journal:  Clin Rheumatol       Date:  2004-06-15       Impact factor: 2.980

7.  Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.

Authors:  Ihab Younis; Lyne Khair; Miroslav Dundr; Michael D Lairmore; Genoveffa Franchini; Patrick L Green
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 8.  HTLV-1 and associated adult T-cell leukemia/lymphoma.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Rev Clin Exp Hematol       Date:  2003-12

Review 9.  Exploiting internal ribosome entry sites in gene therapy vector design.

Authors:  S M Ngoi; A C Chien; C G L Lee
Journal:  Curr Gene Ther       Date:  2004-03       Impact factor: 4.391

10.  HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.

Authors:  Jianxin Ye; Lee Silverman; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  9 in total

1.  Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone.

Authors:  Sébastien Alain Chevalier; Marine Walic; Sara Calattini; Adeline Mallet; Marie-Christine Prévost; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

2.  Evidence for cooperative transforming activity of the human pituitary tumor transforming gene and human T-cell leukemia virus type 1 Tax.

Authors:  Sergey V Sheleg; Jean-Marie Peloponese; Ya-Hui Chi; Yan Li; Michael Eckhaus; Kuan-Teh Jeang
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

3.  HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.

Authors:  Jacob Al-Saleem; Wessel P Dirksen; Michael P Martinez; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Lee Ratner; Patrick L Green
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

Review 4.  CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1.

Authors:  Amanda R Panfil; Patrick L Green; Kristine E Yoder
Journal:  Front Cell Infect Microbiol       Date:  2020-12-23       Impact factor: 5.293

5.  HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models.

Authors:  Victoria Maksimova; Susan Smith; Jaideep Seth; Cameron Phelps; Stefan Niewiesk; Yorifumi Satou; Patrick L Green; Amanda R Panfil
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

6.  Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective.

Authors:  Nishat Aliya; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Leuk Res Treatment       Date:  2012-02-09

7.  Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels.

Authors:  James M Bogenberger; Paul J Laybourn
Journal:  Retrovirology       Date:  2008-01-31       Impact factor: 4.602

Review 8.  Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.

Authors:  Maria Lina Tornesello; Clorinda Annunziata; Anna Lucia Tornesello; Luigi Buonaguro; Franco Maria Buonaguro
Journal:  Cancers (Basel)       Date:  2018-06-22       Impact factor: 6.639

Review 9.  Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.

Authors:  Victoria Maksimova; Amanda R Panfil
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.